Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Resolution plans to use Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Novo Nordisk’s chief scientific officer Marcus Schindler led the keynote address at ELRIG Drug Discovery 2024 in London, UK.

Vevizye is used to treat moderate to severe DED in adults unresponsive to tear substitutes. Novaliq and Laboratoires Théa ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer ...

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...